Navigation Links
Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax

Anthrax vaccine administered in combination with a short course of antibiotics completely protected nonhuman primates from inhalational anthrax, the most lethal form of the disease, according to scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID).

In a collaborative study involving USAMRIID and the National Institute of Allergy and Infectious Diseases (NIAID), investigators demonstrated that postexposure vaccination can shorten the duration of antibiotic treatment required to protect against inhalational anthrax. The findings, which appear in this week's online edition of Proceedings of the National Academy of Sciences, could have important implications for public health management of anthrax bioterrorism events.

Anthrax is caused by the spore-forming bacterium Bacillus anthracis, and causes three types of disease--cutaneous, gastrointestinal, and inhalational--depending upon the route of exposure. Inhalational anthrax--the type likely to occur following a bioterrorist attack--is difficult to diagnose early, and despite antibiotic therapy, has a high fatality rate. In addition, because anthrax spores can remain in the body for extended periods, antibiotic treatment is typically recommended for 60 days or more following exposure.

As noted by the authors, following the 2001 anthrax attacks in the United States, approximately 10,000 people were offered 60 days of antibiotic therapy to prevent inhalational anthrax. Adverse events associated with this regimen--including diarrhea, nausea, vomiting, and dizziness--were commonly reported. More importantly, only about 44 percent of people completed the whole 60-day course. Thus, minimizing the duration of postexposure antibiotic treatment could be crucial to a successful defense against a large-scale anthrax attack.

In the study, two groups of rhesus macaques were exposed to very high amounts of anthrax spores by aerosol. Both groups were then given ci
'"/>

Source:US Army Medical Research Institute of Infectious Diseases


Page: 1 2 3

Related biology news :

1. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
2. Live Recombinant Adenovirus Vaccine Technique Explored
3. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
4. NIAID Initiates Trial of Experimental Avian Flu Vaccine
5. Study Models Impact Of Anthrax Vaccine
6. New Insights Into HIV Immunity Suggest Alternative Approach to Vaccines
7. Pathogen-Mimicking Vaccine As Strategy For Cancer Therapy
8. EuroVacc 02 HIV Vaccine Trial Begins
9. Active Vaccine Prevents Mice From Developing Prion Disease
10. New Vaccine To Be Used For First Time In Polio Outbreak Response
11. Boosting The BCG Vaccine To Beat Tuberculosis

Post Your Comments:
(Date:11/24/2009)..., BATON ROUGE Antarctica has long held secrets o...d until recently, there has been very little infor...eneath miles of ice for millions of years. Now, a ...ing LSU have been funded to the tune of $10 milli...NSF, to get to the bottom of things literally. Th...
(Date:11/24/2009)... This release is available in Spanish . , ...higher levels of inflammatory substances in the bl...ht; as shown by a research project of the Universi...o, a scientist at the School of Pharmacy. , The ... study in relation to the control of body weight a...
(Date:11/23/2009)..., Cambridge, Mass. November 23, 2009 Applied ...ntain lily ( Hosta lancifolia ), a characteristic ...osely packed ripples along the edges. The simple c...n resulting from bending during differential growt..., stretching foam ribbons. , Haiyi Liang, a post...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2It can be predicted the reaction obese patients will have to a diet 2The cause behind the characteristic shape of a long leaf revealed 2Washington DC Plastic Surgeon Mark E Richards M D Says Bio Identical Hormone Therapy has Staggering Health Benefits that Could Change the Way We A 52179 1Washington DC Plastic Surgeon Mark E Richards M D Says Bio Identical Hormone Therapy has Staggering Health Benefits that Could Change the Way We A 52179 2Washington DC Plastic Surgeon Mark E Richards M D Says Bio Identical Hormone Therapy has Staggering Health Benefits that Could Change the Way We A 52179 3Washington DC Plastic Surgeon Mark E Richards M D Says Bio Identical Hormone Therapy has Staggering Health Benefits that Could Change the Way We A 52179 4National Cancer Institute Research Identifies Unique Mechanism of Brostallicins Anti Tumor Effectiveness 4754 1National Cancer Institute Research Identifies Unique Mechanism of Brostallicins Anti Tumor Effectiveness 4754 2National Cancer Institute Research Identifies Unique Mechanism of Brostallicins Anti Tumor Effectiveness 4754 3National Cancer Institute Research Identifies Unique Mechanism of Brostallicins Anti Tumor Effectiveness 4754 4SAFC Supply Solutions 28R 29 Announces Raw Materials Line Developed Specifically to Meet Molecular Diagnostics Manufacturing Requirements 13111 1SAFC Supply Solutions 28R 29 Announces Raw Materials Line Developed Specifically to Meet Molecular Diagnostics Manufacturing Requirements 13111 2SAFC Supply Solutions 28R 29 Announces Raw Materials Line Developed Specifically to Meet Molecular Diagnostics Manufacturing Requirements 13111 3
...y professor and his colleagues have found evidence...stributed in the atmosphere and may play a large r... of David Sands, MSU professor of plant sciences a...stine Foreman, an MSU professor of land resources ...ouisiana State University and Cindy Morris, will b...
...istner, LSU professor of biological sciences, in p...recently found evidence that rain-making bacteria ...ological particles could factor heavily into the p...l productivity and even global warming. Christner ...he prestigious journal Science on Feb. 29. , Chri...
...008 Utilizing a technique that combines low tempe...Hebrew University of Jerusalem scientists and othe... structure of single DNA molecules. , The knowle...rtant issue in many scientific areas from biochemi... of DNA damage by ultraviolet radiation that may c...
Other Biology News:Airborne bacteria may play large role in precipitation 2Airborne bacteria may play large role in precipitation 3LSU scientist finds evidence of 'rain-making' bacteria 2Electronic structure of DNA revealed for 1st time by Hebrew University and collaborating researchers 2
(Date:11/24/2009)... Health care employment grew b...e only one to show consistent growth during the U....tals remain in trouble, and health systems are com...nnel, instead of just administrators. , ... care employment continued growing in October desp...
(Date:11/24/2009)... SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Neu...nyfocusedondevelopingandcommercializingnovelpainma...,PresidentandChiefExecutiveOfficer,isscheduledtopr...ce,tobeheldDecember1-2,2009atTheNewYorkPalaceHotel...ieri,ChiefFinancialOfficer,willbeavailabletorespon...
(Date:11/24/2009)... The FBI recently approved the P...ies participating in or generating DNA records for... Madison, WI USA (PRWEB) -- The FBI recent...em for use by laboratories participating in, or g...System (NDIS). NDIS currently contains more than s...
(Date:11/24/2009)... DUBLIN,November24/PRNewswire-FirstCall/--Shireplc...rmaceuticalcompany,today,announcedthatithassubmitt...ealfa,thecompany,senzymereplacementtherapyindevelo...hethirdmarketing,applicationforvelaglucerasealfath...itedStatesandCanada. , Basedonaglobalsupplysh...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...ng its Launch in 2010, Myriad Genetics, Flurizan W... According to a New Report from Decision ...eb. 5 Decision Resources, one of the,world,s lead...ceutical and,healthcare issues, finds that a drug,...nitive impairment to Alzheimer,s disease is the at...
...K, Feb. 5 Forest Laboratories, Inc.,(NYSE: FRX )...I study of,memantine HCl (currently marketed as Na...tion) in a novel once-daily formulation. The study...of an innovative, proprietary, 28 mg,memantine ext...placebo in,outpatients with moderate to severe Alz...
...NCISCO, Feb. 5 DiObex, Inc., a privately held,bio...herapeutics to treat,metabolic diseases, announced...e presentation at the upcoming Merrill Lynch & Co,...ical Device Conference in New York,New York. The D...eb. 6 at,10:20 a.m. at the Grand Hyatt Hotel in th...
Other Biology Technology:Flurizan's Effect in Delaying Progression From Mild Cognitive Impairment to Alzheimer's Disease is Superior to That of Aricept 2Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation 2Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation 3Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation 4
HV Mini 3 (230V / 50Hz) from Thermo Scientific
Horizontal Plus 0.9 (230V / 50Hz) from Thermo Scientific
Horizontal Basis 1.2 (230V / 50Hz) from Thermo Scientific
...Incubated Orbital Shakers combine high durability ...ce and ease of use. The patented triple-counterbal...owing the unit to run at high speed with heavy, ou...rature range is delivered with tight uniformity by...
Biology Products: